Page last updated: 2024-09-05

sorafenib and 1-naphthylamine

sorafenib has been researched along with 1-naphthylamine in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (1-naphthylamine)	Trials (1-naphthylamine)	Recent Studies (post-2010) (1-naphthylamine)
6,520	730	5,251	1,088	137	194

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ichimura, Y; Imamura, R; Kojima, H; Komatsu, M; Mashino, T; Nagano, T; Ohe, T; Okabe, T; Takahashi, K; Yamamoto, M; Yasuda, D	1

Other Studies

1 other study(ies) available for sorafenib and 1-naphthylamine

Article	Year
Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line. Free radical research, 2020, Volume: 54, Issue:11-12 Topics: 1-Naphthylamine; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Naphthalenes; NF-E2-Related Factor 2; Phosphorylation; Protein Interaction Domains and Motifs; RNA-Binding Proteins; Sorafenib; Sulfonamides	2020

Article

Year

Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line.

Free radical research, 2020, Volume: 54, Issue:11-12

Topics: 1-Naphthylamine; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Naphthalenes; NF-E2-Related Factor 2; Phosphorylation; Protein Interaction Domains and Motifs; RNA-Binding Proteins; Sorafenib; Sulfonamides

2020